Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors
Main Authors: | Tomoya Sagawa, Ken-ichiro Inoue, Hirohisa Takano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Critical Care |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-03235-4 |
Similar Items
-
Clinical cardiac manifestations in patients with coronavirus disease 2019 (COVID-19)
by: Hafizha Herman, et al.
Published: (2020-06-01) -
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
by: Yunjeong Kim, et al.
Published: (2016-03-01) -
Correction: Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
by: Yunjeong Kim, et al.
Published: (2016-05-01) -
A Family Cluster of Coronavirus Disease (COVID-19) Infection with Different Clinical Manifestations
by: Soedarsono Soedarsono
Published: (2020-08-01) -
Role of salivary leukocyte protease inhibitor in periodontal disease progression
by: Pateel Deepak, et al.
Published: (2010-01-01)